---
layout: post
title: "Peripheral Percutaneous Transluminal Angioplasty and Specialty Catheters-Premarket Notification (510(k)) Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 19:08:04 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-00296
original_published: 2020-01-13 00:00:00 +0000
significance: 8.00
---

# Peripheral Percutaneous Transluminal Angioplasty and Specialty Catheters-Premarket Notification (510(k)) Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** January 13, 2020 00:00 UTC
**Document Number:** 2020-00296

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters-- Premarket Notification (510(k)) Submissions; Draft Guidance for Industry and Food and Drug Administration Staff." The FDA is issuing this draft guidance document to provide recommendations for 510(k) submissions for peripheral percutaneous transluminal angioplasty (PTA) balloons and specialty catheters (e.g., infusion catheters, PTA balloon catheters for in-stent restenosis (ISR), scoring/cutting balloons). This draft guidance is not final nor is it in effect at this time.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/01/13/2020-00296/peripheral-percutaneous-transluminal-angioplasty-and-specialty-catheters-premarket-notification-510k)
- API: https://www.federalregister.gov/api/v1/documents/2020-00296

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
